About James Jenson
Form D filings for Morphoceuticals in 2024 list James Jenson as chief executive officer and director.
James Jenson first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name James Jenson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Jenson works with at each company, as listed on that company's latest Form D.
Morphoceuticals, Inc. · Form D, Oct 7, 2024
MH
Michael Hufford
Director
AP
Alexander Pickett
Director
JB
Justin Briggs
Director
TT
Tamim Al-Thani
Director
RH
Rosemarie Hunziker
Director